Sampson Shirlene M, Rome Jeffrey D, Rummans Teresa A
Department of Psychiatry and Psychology, W11A, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Pain Med. 2006 Mar-Apr;7(2):115-8. doi: 10.1111/j.1526-4637.2006.00106.x.
Evidence suggests that fibromyalgia (FM) is a centrally mediated pain disorder. Antidepressants, including electroconvulsive therapy, provide some symptomatic relief in FM and other pain disorders. Repetitive transcranial magnetic stimulation (rTMS) is a new antidepressant treatment, which may also be useful in treating chronic pain.
As part of a larger study, four women with depression, FM, and borderline personality disorder received 1-Hz rTMS applied to the right dorsolateral prefrontal cortex. Subjects rated pain using an 11-point Likert scale.
Pretreatment pain averaged 8.2 (7-9.5) and reduced to 1.5 (0-3.5) after treatment (P < 0.009). All had improvement in pain, and two had complete resolution of pain. Only one of the four subjects had an antidepressant response.
These preliminary findings suggest a possible role for rTMS in treating FM.
有证据表明纤维肌痛(FM)是一种中枢介导的疼痛障碍。包括电休克疗法在内的抗抑郁药可使FM及其他疼痛障碍的症状得到一定缓解。重复经颅磁刺激(rTMS)是一种新型抗抑郁治疗方法,可能对治疗慢性疼痛也有用。
作为一项更大规模研究的一部分,4名患有抑郁症、FM和边缘型人格障碍的女性接受了应用于右侧背外侧前额叶皮质的1赫兹rTMS治疗。受试者使用11点李克特量表对疼痛进行评分。
治疗前疼痛平均评分为8.2(7 - 9.5),治疗后降至1.5(0 - 3.5)(P < 0.009)。所有患者的疼痛均有改善,其中2名患者疼痛完全缓解。4名受试者中只有1人有抗抑郁反应。
这些初步研究结果表明rTMS在治疗FM中可能发挥作用。